Zimmer Biomet Holdings, Inc. Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Leerink Partners Remains Bullish on Zimmer Biomet Holdings (ZBH) Following an In-Line 3Q
October 30, 2015 11:54 AM EDTLeerink Partners maintained an Outperform rating on Zimmer Holdings (NYSE: ZBH), and cut the price target to $125.00 (from $130.00), following the company's 3Q earnings results. 3Q revenues of $1.76B was in-line with consensus, along with of $1.64.
Analyst Richard Newitter commented, "Expectations were low, but ZBH's 3Q... More
Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 8c; Boosts FY15 EPS Outlook
October 29, 2015 7:41 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.64, $0.08 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.76 billion versus the consensus estimate of $1.76 billion.
Zimmer Biomet Holdings sees FY2015 EPS of $6.83-$6.87, versus prior guidance of $6.65-$6.80 and... More
